Johnson & Johnson was named in an ERISA class action on Feb. 5 in New Jersey federal court filed by Wheeler, DiUlio & Barnabei and Fairmark Partners that accused the company and its pension and benefits committee of failing to prudently manage its prescription drug benefits plan.